Find generic entry opportunities
Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Metered dose inhaler for albuterol|
|Abstract:||A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising fluticasone propionate or a physiologically acceptable solvate thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.|
|Inventor(s):||Ashurst; Ian C. (Ware, GB), Britto; Ignatius Loy (Cary, NC), Herman; Craig Steven (Raleigh, NC), Li-Bovet; Li (Chapel Hill, NC), Riebe; Michael Thomas (Raleigh, NC)|
|Assignee:||SmithKline Beecham Corporation (Philadelphia, PA)|
Patent Claim Types:|
see list of patent claims
|Composition; Formulation; Delivery; Device; Use;|
Field: Medical technology
Back Citations: 135th percentile
Forward Citations: 0th percentile
|Patent Number||Expiration Date|
|6,532,955||March 18, 2015|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Czech Republic||292578||► subscribe|
|Czech Republic||9703259||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.